GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Heidelberg Pharma HPHA.DE · EUR

Health Care · XETRA · 🇩🇪 Germany

Compare

2.19

+2.34%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Heidelberg Pharma — daily XETR:HPHA End of day
Market value
€102.1m
Last close × shares
Volume
2.2k
Shares, 9 Nov 2026

About Heidelberg Pharma

Its shares trade on XETRA under the ticker HPHA.DE. It has been listed since 13 November 2006. In the fiscal year to 30 November 2025, it reported revenue of €1.5m and a net loss of €42.3m. At that date it held total assets of €38.1m and shareholders' equity of −€10.9m.

Heidelberg Pharma AG is a holding company, which engages in the development of diagnostic and therapeutic oncology products for the detection and targeted treatment of various types of cancer. The company is headquartered in Ladenburg, Baden-Wuerttemberg. The company went IPO on 2006-11-13. The firm focuses on the research and development of therapy treatments for oncology area. The company aims at applying toxin Amanitin into cancer therapies using its Antibody Targeted Amanitin Conjugate (ATAC) technology. The Company’s pipeline includes a number of drug candidates, such as HDP-101, a B-cell maturation antigen ATAC for multiple myeloma; PSMA-ATAC, prostate-specific membrane antigens, and CD19-ATAC, a B-lymphocyte antigen. Through partnerships, the Company develops clinical assets, including MESUPRON, REDECTANE and RENCAREX. The company also offers preclinical contract research services.

Figures and description from our data supplier, not checked against the company's own report.

More about Heidelberg Pharma →

Latest on Heidelberg Pharma

Our reporting

We have not reported on Heidelberg Pharma yet.

Next results

3 Feb 2027

Due on 3 Feb 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Heidelberg Pharma's ticker?

Heidelberg Pharma trades as HPHA.DE on XETRA, under ISIN DE000A11QVV0.

What was Heidelberg Pharma's last closing price?

2.19 on 9 Nov 2026. The figure is in EUR and is never converted.

When does Heidelberg Pharma next report results?

Results are expected on 3 Feb 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.